Olympus has been granted a patent for a resin composition for medical devices to undergo gas low-temperature sterilization. The composition includes a resin and an ion exchanger. The patented medical device comprises urethane or polyurethane along with the ion exchanger. GlobalData’s report on Olympus gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Olympus Corp - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Olympus, AI-assisted medical imaging was a key innovation area identified from patents. Olympus's grant share as of January 2024 was 28%. Grant share is based on the ratio of number of grants to total number of patents.

Resin composition for medical devices for low-temperature sterilization

Source: United States Patent and Trademark Office (USPTO). Credit: Olympus Corp

A recently granted patent (Publication Number: US11883563B2) discloses a medical device designed for gas low-temperature sterilization. The device includes a resin composition comprising urethane or polyurethane and an ion exchanger. The ion exchanger contains an inorganic substance that discharges hydroxide ions or protons, with a content ranging from 0.01 to 40 parts by mass with respect to 100 parts by mass of the resin. This innovative medical device aims to enhance sterilization processes effectively and efficiently.

Furthermore, the patent includes various embodiments of the medical device, such as a flexible tube for a medical device, an endoscope with an ultrasound probe, an acoustic lens, and a sheath. These components also consist of resin compositions with specific materials like fluorinated elastomer or silicone along with an ion exchanger. The inclusion of these materials in the medical devices allows for gas low-temperature sterilization, ensuring the safety and effectiveness of the devices during medical procedures. Overall, the patent highlights the importance of incorporating specific resin compositions and ion exchangers in medical devices to improve sterilization processes and maintain optimal performance in healthcare settings.

To know more about GlobalData’s detailed insights on Olympus, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.